Overuse of Tuberculosis Surveillance Testing in Patients With Inflammatory Bowel Disease Compared to Non-IBD Patients on Biologic Therapy

BACKGROUND: Biologic treatment for moderate to severe inflammatory bowel disease (IBD) places patients at risk for infectious complications. Tuberculosis (TB) infection and reactivation can lead to serious morbidity and mortality for immunosuppressed patients. As a result, guidelines recommend scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Fine, Sean, Vecchio, Marc, Filipe Goncalves Monteiro, Joao, Vecchio, Eric, Mao, Eric J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802072/
https://www.ncbi.nlm.nih.gov/pubmed/36776652
http://dx.doi.org/10.1093/crocol/otab026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802072/
https://www.ncbi.nlm.nih.gov/pubmed/36776652
http://dx.doi.org/10.1093/crocol/otab026

Ejemplares similares